Zobrazeno 1 - 10
of 108
pro vyhledávání: '"I. G. RUSAKOV"'
Autor:
A. A. Gritskevich, A. Yu. Popov, I. G. Rusakov, E. K. Vozniy, V. A. Makarov, D. I. Gridnev, T. P. Baitman, S. V. Mishugin, I. V. Novikova, S. V. Khromova
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 95-103 (2022)
Urothelial cancer occupies a significant place in the routine practice of cancer treatment. Systemic antitumor treatment of patients with metastatic urothelial cancer in the first line is currently well studied, has its own standards, implemented in
Externí odkaz:
https://doaj.org/article/78a16071fc2a4c12b22247798a092ea2
Publikováno v:
Медицинский совет, Vol 0, Iss 4S, Pp 44-50 (2021)
Prostate cancer (PC) is one of the leading causes of cancer death in the male population. Currently, the pathogenesis of prostate cancer has been studied in sufficient detail, which makes a successful radical treatment possible in most cases. However
Externí odkaz:
https://doaj.org/article/264c7bce8db248fa8d6208f270b8a9d6
Publikováno v:
Медицинский совет, Vol 0, Iss 20, Pp 70-82 (2020)
Bone metastases often develop in patients with prostate cancer (PC) as a natural stage in the course of the disease. The skeletal system is the most typical and sometimes even the only site of metastatic prostate cancer. The involvement of bones is a
Externí odkaz:
https://doaj.org/article/169cb0cee99b41e3a1a43de06142068d
Publikováno v:
Медицинский совет, Vol 0, Iss 20, Pp 100-108 (2020)
This review is dedicated to the impact of modern achievements on the definition and diagnostics of castration-resistant prostate cancer (PCa) (CRPC), prognostic factors for its progression, and treatment strategies.It was proven with new sensitive me
Externí odkaz:
https://doaj.org/article/7ac97b2388e446fa951b39918a80e0c5
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 136-145 (2020)
The standards of treatment for metastatic renal cell carcinoma (mRCC) have changed significantly from unsuccessful attempts of radiation and cytostatic therapy to the encouraging results of targeted therapy and specific immunotherapy. Sunitinib has g
Externí odkaz:
https://doaj.org/article/57c8d517064a4653b1c6f70c85ec54fd
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 156-162 (2019)
Prostate cancer (PC) is one of the major health problems of the male population. The most difficult is the treatment of metastatic castration-resistant prostate cancer (mCRPC), which is the main cause of mortality from PC. In the course of treatment
Externí odkaz:
https://doaj.org/article/12724b4dd40d404b8eb2a34779245746
Autor:
I. G. Rusakov, S. V. Mishugin
Publikováno v:
Медицинский совет, Vol 0, Iss 19, Pp 85-88 (2018)
Интервью с вице-президентом Российского общества онкоурологов (РООУ), врачом-онкологом Московской городской клинической больницы № 57,
Externí odkaz:
https://doaj.org/article/b3e68e08fcf04c90aef4b7a73e367481
Publikováno v:
Медицинский совет, Vol 0, Iss 14, Pp 82-87 (2017)
Therapy of CRPC is one of the most difficult problems in oncourology. Until now the optimal consequence of use of drugs in CRPC is not determined.Study objective: evaluation of effectiveness of sequential therapeutic schemes in progression of m-CRPC:
Externí odkaz:
https://doaj.org/article/f9c1b7d776384a4ab88e763b7e2cc77f
Publikováno v:
Медицинский совет, Vol 0, Iss 6, Pp 110-116 (2017)
This article provides a critical overview of the methods of optical diagnosis of muscular and non-invasive bladder cancer (BC), describes the technologies available so far, their advantages and disadvantages, and reviews the assessment of their effec
Externí odkaz:
https://doaj.org/article/2e3f35d2f43844de9f0cd74a7fb34cdb
Publikováno v:
Медицинский совет, Vol 0, Iss 6, Pp 98-102 (2017)
Our surveillance was performed for 358 patients with locally advanced and disseminated prostate gland cancer who were treated by analogues of LHRH. Patients in group 1 (n = 222) received treatment with a LHRH analogue, and patients in group 2 (n = 13
Externí odkaz:
https://doaj.org/article/87cf51ffcf484744beba2e5c11cda7d5